Multicenter phase II study in advanced pancreatic adenocarcinoma patients treated with a combination of leucovorin, 5FU bolus and infusion, and emcitabine (FOLFUGEM regimen).

被引：0
|
作者：
Hammel, P [1 ]
Louvet, C [1 ]
Andre, T [1 ]
Vanica, R [1 ]
Landi, B [1 ]
Balosso, J [1 ]
Cattan, S [1 ]
Fonck, M [1 ]
Flesch, M [1 ]
Colin, P [1 ]
Gruson, T [1 ]
de Gramont, A [1 ]
机构：
[1] Hosp Beaujon, Clichy, France
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G1828
引用
收藏
页码：A417 / A417
页数：1
相关论文
共 50 条
  • [1] Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
    Louvet, C
    André, T
    Hammel, P
    Selle, F
    Landi, B
    Cattan, S
    Fonck, M
    Flesch, M
    Colin, P
    Balosso, J
    Ruszniewski, P
    de Gramont, A
    ANNALS OF ONCOLOGY, 2001, 12 (05) : 675 - 679
  • [2] PHASE-1 STUDY OF 5FU - METHYL CCNU - METHOTREXATE WITH LEUCOVORIN IN ADVANCED ADENOCARCINOMA
    NIXON, DW
    VOGLER, WR
    JACOBS, J
    HEFFNER, LT
    WINTON, EF
    GARRETT, PR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 326 - 326
  • [3] AN INTERMITTENT LEUCOVORIN CALCIUM (LV) 5-FLUOROURACIL (5FU) REGIMEN FOR ADVANCED ADENOCARCINOMA OF THE COLON
    BRUCKNER, HW
    HART, R
    SPIGELMAN, M
    FEUER, R
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 202 - 202
  • [4] Hydroxyurea, folinic acid, 5FU bolus and infusion (HLFP regimen) in advanced gastric cancer
    Louvet, C
    deGramont, A
    Beerblock, K
    Mal, F
    Ciribilli, JM
    Varette, C
    Demuyck, B
    Raymond, E
    Gamelin, E
    Colin, P
    Krulik, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 557 - 557
  • [5] Hydroxyurea, folinic acid, 5FU bolus and infusion (HLFP regimen) in advanced esophageal cancer
    Ciribilli, JM
    Louvet, C
    Raymond, E
    Beerblock, K
    Varette, C
    Carola, E
    deGramont, A
    Krulik, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 553 - 553
  • [6] Randomized phase III trial comparing 5FU bolus and low dose leucovorin versus 5FU bolus plus continuous 5FU infusion and high dose LV in metastatic colorectal cancer
    Bosset, JF
    DeGrammont, A
    Milan, C
    Rougier, P
    Bouche, O
    Etienne, PL
    Morvan, F
    Louvet, C
    Guillot, T
    Bedenne, L
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 702 - 702
  • [7] Combination of leucovorin, 5-FU bolus and infusion, plus cisplatin (LV5FU2-CDDP regimen) in the treatment of advanced pancreatic (PC) and biliary tract carcinomas (BTC).
    Taïeb, J
    Boige, V
    Mitry, E
    Artru, P
    Vaillant, JN
    Clavero-Fabri, MC
    Lesur, G
    Dupuy, P
    Rougier, P
    Ducreux, M
    ANNALS OF ONCOLOGY, 2000, 11 : 68 - 68
  • [8] Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2)
    André, T
    Noirclerc, M
    Hammel, P
    Meckenstock, R
    Landi, B
    Cattan, S
    Selle, F
    Codoul, JF
    Guerrier-Parmentier, B
    Mokhtar, R
    Louvet, C
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (8-9): : 645 - 650
  • [9] A phase Ib study of oxaliplatin in combination with fluorouracil (5FU) and leucovorin (LV) in pediatric patients (pts) with advanced solid tumors
    Gore, L.
    Kuttesch, J.
    Hunger, S. P.
    Herzog, C.
    Narendaren, A.
    Boklan, J.
    Foreman, N. K.
    Ivy, S. P.
    Boucher, N.
    Trippett, T. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
    S Rao
    D Cunningham
    R E Hawkins
    M E Hill
    D Smith
    F Daniel
    P J Ross
    J Oates
    A R Norman
    British Journal of Cancer, 2005, 92 : 1650 - 1654
12345